Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

U.S. Stem Cell, Inc. USRM

Full chart Compare
Set alert

Price alert · USRM

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.00001 52-week range 0.0002
YTD
0.00%
1 year
0.00%

Financial health

Altman Z-Score

-3283.53 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.0×
FY 2013: -0.8×FY 2014: -2.3×FY 2015: -0.5×FY 2016: -0.0×FY 2017: -2.6×FY 2018: -2.7×FY 2019: -0.3×FY 2020: -1.8×FY 2021: -0.8×FY 2022: -1.0×
FY 2013 5y median -1.0× FY 2022
P/S 34.6×
FY 2013: 26.2×FY 2014: 2.5×FY 2015: 0.4×FY 2016: 0.0×FY 2017: 1.6×FY 2018: 0.9×FY 2019: 0.5×FY 2020: 18.9×FY 2021: 13.8×FY 2022: 34.6×
FY 2013 5y median 13.8× FY 2022
P/B -0.2×
FY 2013: -0.2×FY 2014: -0.5×FY 2015: -0.1×FY 2016: -0.0×FY 2017: -1.3×FY 2018: -0.9×FY 2019: -0.1×FY 2020: -0.5×FY 2021: -0.2×FY 2022: -0.2×
FY 2013 5y median -0.2× FY 2022
P/FCF -9.3×
FY 2013: -1.3×FY 2014: -4.6×FY 2015: -0.9×FY 2016: 0.5×FY 2017: 7.3×FY 2018: 9.7×FY 2019: -1.2×FY 2020: -10.9×FY 2021: -2.6×FY 2022: -9.3×
FY 2013 5y median -2.6× FY 2022
EV/EBITDA -5.4×
FY 2013: -2.9×FY 2014: -17.2×FY 2015: 62.2×FY 2016: -5.6×FY 2017: -4.9×FY 2018: -18.8×FY 2019: -2.9×FY 2020: -5.9×FY 2021: -70.9×FY 2022: -5.4×
FY 2013 5y median -5.9× FY 2022
EV/Sales 144×
FY 2013: 84.8×FY 2014: 5.1×FY 2015: 2.5×FY 2016: 1.6×FY 2017: 2.4×FY 2018: 1.4×FY 2019: 2.5×FY 2020: 45.8×FY 2021: 53.5×FY 2022: 144×
FY 2013 5y median 45.8× FY 2022
FCF Yield -10.7%
FY 2013: -76.4%FY 2014: -21.8%FY 2015: -106.1%FY 2016: 211.6%FY 2017: 13.7%FY 2018: 10.3%FY 2019: -86.9%FY 2020: -9.1%FY 2021: -38.3%FY 2022: -10.7%
FY 2013 5y median -10.7% FY 2022

Profitability

Gross Margin 71.0%
FY 2013: 67.9%FY 2014: 58.9%FY 2015: 55.6%FY 2016: 68.5%FY 2017: 65.8%FY 2018: 68.5%FY 2019: 56.5%FY 2020: 76.9%FY 2021: 74.1%FY 2022: 71.0%
FY 2013 5y median 71.0% FY 2022
Operating Margin -2096.9%
FY 2013: -2947.1%FY 2014: -171.7%FY 2015: -118.9%FY 2016: -37.6%FY 2017: -14.6%FY 2018: -16.4%FY 2019: -111.2%FY 2020: -866.2%FY 2021: -1063.9%FY 2022: -2096.9%
FY 2013 5y median -866.2% FY 2022
Net Margin -3483.2%
FY 2013: -3271.3%FY 2014: -109.6%FY 2015: -74.9%FY 2016: -67.1%FY 2017: -63.1%FY 2018: -32.2%FY 2019: -124.8%FY 2020: -1043.2%FY 2021: -1637.6%FY 2022: -3483.2%
FY 2013 5y median -1043.2% FY 2022
ROE 19.4%
FY 2013: 22.9%FY 2014: 20.7%FY 2015: 21.3%FY 2016: 25.8%FY 2017: 49.0%FY 2018: 31.4%FY 2019: 40.5%FY 2020: 25.0%FY 2021: 25.8%FY 2022: 19.4%
FY 2013 5y median 25.8% FY 2022
ROIC 29.9%
FY 2013: 36.9%FY 2014: 64.4%FY 2015: 84.9%FY 2016: 42.0%FY 2017: 49.7%FY 2018: 66.8%FY 2019: 104.1%FY 2020: 59.4%FY 2021: 45.5%FY 2022: 29.9%
FY 2013 5y median 59.4% FY 2022
ROA -4200.4%
FY 2013: -3649.1%FY 2014: -1100.4%FY 2015: -716.6%FY 2016: -484.1%FY 2017: -217.9%FY 2018: -118.9%FY 2019: -4268.9%FY 2020: -3279.0%FY 2021: -6446.0%FY 2022: -4200.4%
FY 2013 5y median -4200.4% FY 2022

Growth (YoY)

Revenue -59.1%
FY 2013: 57.2%FY 2014: 2039.6%FY 2015: 6.6%FY 2016: 40.7%FY 2017: 79.0%FY 2018: 21.4%FY 2019: -54.2%FY 2020: -91.0%FY 2021: -27.6%FY 2022: -59.1%
FY 2013 FY 2022
Operating Income 19.4%
FY 2013: -11.7%FY 2014: -24.6%FY 2015: 26.2%FY 2016: 55.5%FY 2017: 30.6%FY 2018: -36.4%FY 2019: -211.2%FY 2020: 29.8%FY 2021: 11.0%FY 2022: 19.4%
FY 2013 FY 2022
EPS (diluted) 32.4%
FY 2013: 54.5%FY 2014: 63.1%FY 2015: 61.0%FY 2016: 95.0%FY 2017: 87.4%FY 2018: 47.8%FY 2019: -69.5%FY 2020: 33.0%FY 2021: -6.0%FY 2022: 32.4%
FY 2013 FY 2022
Free Cash Flow 71.2%
FY 2013: -75.4%FY 2014: 41.9%FY 2015: 24.2%FY 2016: 111.8%FY 2017: 1134.4%FY 2018: -51.0%FY 2019: -301.0%FY 2020: 60.5%FY 2021: -120.9%FY 2022: 71.2%
FY 2013 FY 2022

Financial Health

Current Ratio 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.1×FY 2017: 0.2×FY 2018: 0.3×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
Quick Ratio 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.2×FY 2018: 0.2×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
Debt / Equity -0.6×
FY 2013: -0.4×FY 2014: -0.5×FY 2015: -0.6×FY 2016: -0.6×FY 2017: -0.7×FY 2018: -0.7×FY 2019: -0.7×FY 2020: -0.6×FY 2021: -0.6×FY 2022: -0.6×
FY 2013 5y median -0.6× FY 2022
Net Debt / EBITDA -4.1×
FY 2013: -2.0×FY 2014: -8.8×FY 2015: 53.0×FY 2016: -5.6×FY 2017: -1.6×FY 2018: -7.3×FY 2019: -2.4×FY 2020: -3.5×FY 2021: -52.7×FY 2022: -4.1×
FY 2013 5y median -4.1× FY 2022
Interest Coverage -2.5×
FY 2013: -2.0×FY 2014: -2.2×FY 2015: -1.5×FY 2016: -1.0×FY 2017: -1.3×FY 2018: -0.8×FY 2019: -3.5×FY 2020: -4.9×FY 2021: -2.1×FY 2022: -2.5×
FY 2013 5y median -2.5× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31